Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1829 1
1858 1
1907 1
1911 2
1913 1
1917 1
1920 1
1921 1
1923 2
1938 1
1943 1
1946 3
1947 1
1948 7
1949 12
1950 2
1951 6
1952 5
1953 5
1954 4
1955 5
1956 3
1957 6
1958 4
1959 2
1960 6
1961 6
1962 3
1963 6
1964 15
1965 9
1966 9
1967 7
1968 8
1969 8
1970 15
1971 6
1972 11
1973 12
1974 15
1975 15
1976 14
1977 13
1978 10
1979 19
1980 10
1981 16
1982 22
1983 18
1984 15
1985 24
1986 18
1987 13
1988 24
1989 17
1990 17
1991 24
1992 25
1993 16
1994 16
1995 18
1996 14
1997 14
1998 14
1999 15
2000 14
2001 11
2002 19
2003 15
2004 9
2005 20
2006 23
2007 23
2008 26
2009 23
2010 20
2011 29
2012 25
2013 23
2014 18
2015 31
2016 22
2017 25
2018 27
2019 28
2020 26
2021 21
Text availability
Article attribute
Article type
Publication date

Search Results

1,064 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Clément K, et al. Among authors: gordon g. Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-970. doi: 10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. Lancet Diabetes Endocrinol. 2020. PMID: 33137293 Clinical Trial.
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Davids MS, Roberts AW, Seymour JF, Pagel JM, Kahl BS, Wierda WG, Puvvada S, Kipps TJ, Anderson MA, Salem AH, Dunbar M, Zhu M, Peale F, Ross JA, Gressick L, Desai M, Kim SY, Verdugo M, Humerickhouse RA, Gordon GB, Gerecitano JF. Davids MS, et al. Among authors: gordon gb. J Clin Oncol. 2017 Mar 10;35(8):826-833. doi: 10.1200/JCO.2016.70.4320. Epub 2017 Jan 17. J Clin Oncol. 2017. PMID: 28095146 Free PMC article.
Physical activity in depressed and non-depressed patients with obesity.
Sander C, Ueck P, Mergl R, Gordon G, Hegerl U, Himmerich H. Sander C, et al. Among authors: gordon g. Eat Weight Disord. 2018 Apr;23(2):195-203. doi: 10.1007/s40519-016-0347-8. Epub 2017 Feb 10. Eat Weight Disord. 2018. PMID: 28188598 Free PMC article.
Stress gates an astrocytic energy reservoir to impair synaptic plasticity.
Murphy-Royal C, Johnston AD, Boyce AKJ, Diaz-Castro B, Institoris A, Peringod G, Zhang O, Stout RF, Spray DC, Thompson RJ, Khakh BS, Bains JS, Gordon GR. Murphy-Royal C, et al. Among authors: gordon gr. Nat Commun. 2020 Apr 24;11(1):2014. doi: 10.1038/s41467-020-15778-9. Nat Commun. 2020. PMID: 32332733 Free PMC article.
Limiting RyR2 Open Time Prevents Alzheimer's Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid Accumulation.
Yao J, Sun B, Institoris A, Zhan X, Guo W, Song Z, Liu Y, Hiess F, Boyce AKJ, Ni M, Wang R, Ter Keurs H, Back TG, Fill M, Thompson RJ, Turner RW, Gordon GR, Chen SRW. Yao J, et al. Among authors: gordon gr. Cell Rep. 2020 Sep 22;32(12):108169. doi: 10.1016/j.celrep.2020.108169. Cell Rep. 2020. PMID: 32966798 Free PMC article.
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer S, Eichhorst B, Schetelig J, Coutre S, Seymour JF, Munir T, Puvvada SD, Wendtner CM, Roberts AW, Jurczak W, Mulligan SP, Böttcher S, Mobasher M, Zhu M, Desai M, Chyla B, Verdugo M, Enschede SH, Cerri E, Humerickhouse R, Gordon G, Hallek M, Wierda WG. Stilgenbauer S, et al. Among authors: gordon g. Lancet Oncol. 2016 Jun;17(6):768-778. doi: 10.1016/S1470-2045(16)30019-5. Epub 2016 May 10. Lancet Oncol. 2016. PMID: 27178240 Clinical Trial.
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
Basaria S, Collins L, Dillon EL, Orwoll K, Storer TW, Miciek R, Ulloor J, Zhang A, Eder R, Zientek H, Gordon G, Kazmi S, Sheffield-Moore M, Bhasin S. Basaria S, et al. Among authors: gordon g. J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95. doi: 10.1093/gerona/gls078. Epub 2012 Mar 28. J Gerontol A Biol Sci Med Sci. 2013. PMID: 22459616 Free PMC article. Clinical Trial.
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.
Stilgenbauer S, Eichhorst B, Schetelig J, Hillmen P, Seymour JF, Coutre S, Jurczak W, Mulligan SP, Schuh A, Assouline S, Wendtner CM, Roberts AW, Davids MS, Bloehdorn J, Munir T, Böttcher S, Zhou L, Salem AH, Desai M, Chyla B, Arzt J, Kim SY, Verdugo M, Gordon G, Hallek M, Wierda WG. Stilgenbauer S, et al. Among authors: gordon g. J Clin Oncol. 2018 Jul 1;36(19):1973-1980. doi: 10.1200/JCO.2017.76.6840. Epub 2018 May 1. J Clin Oncol. 2018. PMID: 29715056 Clinical Trial.
1,064 results